The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2- Metastatic Breast Cancer Patients


Podcast 2024021

Expert
Eman Aboelkheir'
Assistant lecturer of clinical oncology
Alexandria University
Alexandria, Egypt